SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-002701
Filing Date
2024-01-08
Accepted
2024-01-08 08:00:05
Documents
1
Period of Report
2024-01-05

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 2807
  Complete submission text file 0000950170-24-002701.txt   4227
Mailing Address 103 CARNEGIE CENTER SUITE 300 PRINCETON NJ 08540
Business Address 103 CARNEGIE CENTER SUITE 300 PRINCETON NJ 08540 609-649-9272
Acasti Pharma Inc. (Issuer) CIK: 0001444192 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 217 W. MAIN STREET SOMERVILLE NJ 08876
Business Address
DelAversano Robert J (Reporting) CIK: 0001728262 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35776 | Film No.: 24518378